Neonatal goiter in Oman: Symptoms, Causes & Treatment

Neonatal goiter in Oman: Symptoms, Causes & Treatment | aihealz

§ 02

How you might notice it

01A visible or palpable swelling at the front of the neck, often noticed by the patient while shaving or applying makeup, or by a family member.

02A sense of pressure, tightness, or fullness in the lower neck, particularly when wearing collared shirts or jewelry.

03Difficulty swallowing solid foods (dysphagia) as the gland enlarges and compresses the upper esophagus.

04Difficulty breathing or stridor when lying flat or with the neck extended, due to tracheal compression by a substernal component.

05Hoarseness or change in voice from compression or stretching of the recurrent laryngeal nerve.

06Symptoms of hypothyroidism when the goiter is caused by Hashimoto's or iodine deficiency: fatigue, cold intolerance, weight gain, constipation, dry skin, hair loss, and brain fog.

07Symptoms of hyperthyroidism when the goiter is toxic: heat intolerance, weight loss despite normal appetite, palpitations, tremor, anxiety, and frequent bowel movements.

08A new, rapidly growing neck lump should prompt urgent evaluation for thyroid cancer or anaplastic transformation.

09Facial flushing or fullness when raising the arms above the head (Pemberton sign) — indicates obstruction of venous return by a substernal goiter.

early warning signs

•Mild enlargement of the lower neck noticed only on close inspection or palpation by a clinician
•Elevated TSH on routine bloodwork without symptoms — subclinical hypothyroidism from early Hashimoto's
•Mild dysphagia limited to specific foods (rice, bread) in middle-aged women
•Family history of goiter, autoimmune thyroid disease, or thyroid cancer in first-degree relatives

● emergency signs

•Acute breathlessness or stridor with a known large goiter — possible acute tracheal compression needing airway support
•Sudden severe neck pain with rapid swelling — possible hemorrhage into a nodule requiring urgent imaging
•Hoarseness, vocal cord paralysis, or rapid growth — must exclude thyroid cancer with urgent ultrasound and biopsy
•Thyrotoxic crisis (thyroid storm) — high fever, tachycardia, agitation, vomiting in a patient with untreated toxic goiter — requires ICU care
•Cervical lymphadenopathy with a thyroid mass — possible metastatic thyroid carcinoma requiring biopsy of both

§ 03

How it’s diagnosed

diagnosis

Diagnosis begins with a structured neck examination and is anchored by three questions: how large is the goiter, what is the thyroid function, and are there any suspicious nodules? Inspection identifies asymmetry, scars, and visible bulging; palpation from behind the patient with swallowing assesses size, consistency, mobility, and any discrete nodules. Auscultation may detect the bruit of Graves' disease. Initial laboratory testing is TSH (with reflex free T4 and free T3 if abnormal), thyroid peroxidase antibody (TPO Ab), and thyroglobulin antibody (Tg Ab) to identify autoimmune disease. TSH-receptor antibody (TRAb) is added when Graves' disease is suspected. Ultrasound is the single most useful imaging study: it confirms gland enlargement, characterizes any nodules using the ACR TI-RADS or ATA stratification system (composition, echogenicity, shape, margins, echogenic foci), and identifies suspicious cervical lymphadenopathy. Fine-needle aspiration (FNA) under ultrasound guidance is recommended for nodules ≥1 cm with intermediate or high-suspicion features, or ≥1.5-2 cm for lower-risk nodules, per ATA 2015 guidelines. Bethesda system cytology categories guide management. Radioiodine (I-123) or technetium-99m thyroid scan is used selectively when TSH is suppressed to identify a 'hot' autonomous nodule vs the diffuse uptake of Graves'. CT or MRI without contrast is reserved for very large or substernal goiters to plan surgery; iodinated contrast should be avoided when possible due to thyroid uptake. Spirometry or flow-volume loops can quantify tracheal compression. The combination of TSH plus ultrasound resolves the majority of cases on first visit.

Key tests

Thyroid-stimulating hormone (TSH)The first-line test for thyroid function. Suppressed TSH indicates hyperthyroidism; elevated TSH indicates hypothyroidism. Normal TSH with a goiter typically reflects euthyroid Hashimoto's, multinodular disease, or early iodine deficiency.

Thyroid ultrasound with nodule characterizationConfirms goiter, measures thyroid volume, characterizes any nodules using TI-RADS or ATA criteria, and detects suspicious lymph nodes. The single most useful imaging study for goiter.

TPO and Tg antibodiesConfirm autoimmune thyroiditis (Hashimoto's). Strongly positive TPO antibodies are present in over 90% of Hashimoto's patients and 70% of Graves' patients. Negative antibodies suggest non-autoimmune cause.

Fine-needle aspiration (FNA) of suspicious nodulesDistinguishes benign from malignant nodules. Reported with the Bethesda system, where categories III-VI guide further evaluation or surgery. FNA is the reference standard for nodule risk stratification.

Radioiodine (I-123) or technetium-99m thyroid scanUsed when TSH is suppressed to distinguish Graves' disease (diffuse uptake) from toxic nodular goiter (focal hot nodule with cold surroundings) or thyroiditis (very low uptake).

Free T4 and free T3Confirm and quantify hyperthyroidism or hypothyroidism in patients with abnormal TSH. Free T3 in particular helps identify T3-toxicosis from autonomously functioning nodules.

Cervical CT or MRI (without iodinated contrast)Reserved for large or substernal goiters to define airway compression, retrosternal extent, and surgical planning. Iodinated contrast can precipitate thyrotoxicosis in autonomous nodules and is avoided when possible.

Outlook

Most goiters have an excellent long-term prognosis. Iodine-deficiency goiter responds well to iodization, with significant size reduction in early disease. Hashimoto's leads to progressive hypothyroidism in most patients but is fully controlled with levothyroxine; life expectancy is normal. Graves' disease achieves long-term remission off antithyroid drugs in 40-50% of patients; radioiodine or surgery is curative in over 90%. Toxic multinodular goiter, once treated definitively, rarely recurs. Multinodular goiter without function abnormalities typically grows slowly or stabilizes; only 5-10% of nodules over a decade prove malignant. Thyroid cancers found within goiters have generally favorable outcomes: papillary carcinoma has 10-year survival above 95% in localized disease. Mortality from goiter itself is uncommon and is restricted to large untreated compressive disease, anaplastic carcinoma, or untreated thyroid storm. Pregnancy outcomes are very good when thyroid function is normalized before conception and TSH is maintained in the trimester-specific reference range throughout gestation.

§ 05

Causes & risk factors

known causes

Chronic iodine deficiency: The most common cause worldwide. Sustained dietary iodine below 100 µg/day reduces thyroid hormone production; the pituitary responds by increasing TSH, which drives thyroid hyperplasia. Endemic iodine deficiency persists in mountain and inland regions of Africa, South Asia, and Eastern Europe.
Hashimoto's thyroiditis (chronic autoimmune thyroiditis): The leading cause of goiter in iodine-sufficient countries. Anti-thyroid peroxidase and anti-thyroglobulin antibodies drive lymphocytic infiltration, fibrosis, and slowly progressive thyroid failure. The gland is initially enlarged and firm, becoming smaller and atrophic in late disease.
Graves' disease: Autoimmune diffuse toxic goiter driven by TSH-receptor stimulating antibodies (TRAb), which mimic TSH and cause both diffuse enlargement and overproduction of thyroid hormone. Often accompanied by orbitopathy and pretibial myxedema.
Multinodular goiter (sporadic, non-toxic): Develops over years from focal hyperplasia and clonal expansion within the thyroid. Each nodule reflects a small genetic or acquired change in a single thyrocyte lineage. Prevalence rises with age, reaching 30-50% by age 60 on ultrasound.
Inherited dyshormonogenesis: Rare autosomal recessive defects in thyroid hormone synthesis (TPO, TG, DUOX2, SLC5A5, SLC26A4 mutations) cause congenital goiter, usually with hypothyroidism. Pendred syndrome combines goiter with sensorineural deafness.
Goitrogenic foods and medications: Cassava, soy, millet, and cabbage-family vegetables can contribute to goiter in iodine-deficient settings. Lithium, amiodarone, perchlorate, and excess iodine itself (Wolff-Chaikoff effect or Jod-Basedow) all alter thyroid function and can drive goiter.
Thyroid neoplasms: Both benign (follicular adenoma) and malignant (papillary, follicular, medullary, anaplastic) thyroid neoplasms present as nodules within a goiter. Rapid growth, hard fixed nodules, vocal cord paralysis, and lymphadenopathy raise concern for malignancy.

risk factors

Female sexnon-modifiable: Women have 4-5x higher prevalence of goiter and nodular disease in iodine-sufficient regions, driven partly by estrogen effects on thyroid growth and a higher prevalence of autoimmune thyroid disease.
Iodine intake below WHO recommended levelsmodifiable: Dietary iodine below 100 µg/day in adults (150 µg in pregnancy) drives endemic goiter. Universal salt iodization has reduced goiter prevalence in supplemented countries by 50-80% over decades.
Family history of thyroid diseasegenetic: First-degree relatives with goiter, Hashimoto's, Graves', or thyroid cancer raise individual risk 2-4 fold. Specific susceptibility loci include HLA-DR3, CTLA4, PTPN22, and TSHR.
Pregnancy and postpartumnon-modifiable: Iodine demand rises 50% in pregnancy. Pre-existing borderline iodine deficiency can manifest as gestational goiter. Postpartum thyroiditis occurs in 5-10% of women within 12 months of delivery.
External radiation exposure to the neckenvironmental: Childhood radiation for tinea capitis, acne, lymphoma, or accidental nuclear exposure raises goiter and thyroid cancer risk for decades. Risk peaks for exposures under age 15.
Smokingmodifiable

Living with Neonatal goiter

Timeline

Levothyroxine replacement normalizes TSH over 6-12 weeks. Antithyroid drugs render Graves' patients euthyroid in 4-8 weeks. Radioiodine takes 2-4 months for full effect, with hypothyroidism typically developing within 6-12 months. Thyroidectomy recovery is rapid — most patients return to work within 1-2 weeks; the small surgical scar fades over 6-12 months. Goiter size after iodine repletion or levothyroxine begins to shrink within 3-6 months and reaches maximum reduction by 12 months.

Lifestyle

01Take levothyroxine on an empty stomach with water at least 30-60 minutes before breakfast or other medications
02Separate levothyroxine from calcium, iron, antacids, and soy products by at least 4 hours to avoid impaired absorption
03Inform anesthesiologists and radiologists about your goiter before any neck surgery or iodinated contrast study
04Carry a medical-alert card noting your thyroid status, particularly if on antithyroid drugs that require interruption before surgery
05Maintain regular TSH monitoring every 6-12 months once on stable medication; sooner during pregnancy or major weight changes

Daily management

01Take thyroid medication consistently at the same time each day
02Monitor for symptoms of over- or under-treatment between TSH checks (palpitations, weight change, fatigue, mood changes)
03Report any new neck lump, rapid growth, hoarseness, or breathing difficulty promptly
04Maintain regular TSH monitoring as advised — usually every 6-12 months on stable medication
05Keep a record of past thyroid ultrasound reports and FNA results to support continuity of care

Exercise

Regular aerobic exercise is safe and beneficial with treated goiter. During untreated hyperthyroidism, avoid high-intensity exercise due to cardiac strain — beta-blockers can mitigate symptoms while definitive therapy takes effect. Once euthyroid, no specific exercise restrictions apply. Strength training is particularly helpful in post-surgical recovery and counteracts the muscle weakness that can persist after hypothyroidism.

§ 08

Frequently asked

What is a goiter?

A goiter is an abnormal enlargement of the thyroid gland, the butterfly-shaped gland at the front of the neck. It can be diffuse (uniform) or nodular, and can occur with low, normal, or high thyroid hormone levels.

What causes goiter?

Worldwide, iodine deficiency is the most common cause. In iodine-sufficient countries like the US, autoimmune thyroid disease (Hashimoto's thyroiditis or Graves' disease), benign multinodular changes, and inherited conditions are the leading causes.

Is goiter dangerous?

Most goiters are not immediately dangerous. They become a problem when they grow large enough to compress the trachea, esophagus, or recurrent laryngeal nerve; when they cause hyperthyroidism or hypothyroidism; or when they contain a thyroid cancer.

How is goiter diagnosed?

Diagnosis starts with neck examination and a TSH blood test. Thyroid ultrasound is the single most useful imaging test, confirming enlargement and characterizing any nodules. Antibody tests identify autoimmune causes.

Do all goiters need treatment?

No. Many small, asymptomatic goiters with normal thyroid function are simply monitored with periodic TSH and ultrasound. Treatment is needed for abnormal thyroid function, compressive symptoms, cosmetically significant size, suspicious nodules, or rapid growth.

Will iodine cure my goiter?

Iodine supplementation works well in early iodine-deficiency goiter, particularly in young people with diffuse enlargement. Once long-standing nodular disease has developed, iodine alone is less effective.

Can goiter cause weight gain?

Goiter can cause weight gain when associated with hypothyroidism — typically 3-5 kg of fluid retention and slowed metabolism. Once levothyroxine restores normal thyroid hormone levels, this weight is usually lost over 3-6 months. Goiter with normal thyroid function does not cause weight change.

Is goiter the same as thyroid cancer?

No. Goiter simply means an enlarged thyroid, and the vast majority of goiters are benign. However, thyroid cancers commonly present as nodules within a goiter, which is why suspicious nodules need ultrasound risk stratification and biopsy. About 5-10% of biopsied thyroid nodules are malignant.

Can goiter come back after surgery?

After total thyroidectomy, goiter does not recur because no thyroid tissue remains. After hemithyroidectomy or partial resection, the remaining thyroid lobe can enlarge over years in 5-15% of cases. Patients with multinodular goiter are at higher risk of recurrence than those with solitary nodules.

Does pregnancy affect goiter?

Pregnancy raises thyroid hormone demand approximately 50%. Pre-existing borderline iodine deficiency can manifest as gestational goiter.

Is goiter genetic?

Heritability is moderate. First-degree relatives of patients with goiter, Hashimoto's, Graves', or thyroid cancer have a 2-4 fold higher risk. Specific genes including HLA-DR3, CTLA4, PTPN22, and TSHR contribute to autoimmune goiter risk.

What is a substernal goiter?

A substernal goiter is one that extends below the thoracic inlet into the chest, often causing tracheal compression, dysphagia, or facial flushing on arm raising (Pemberton sign).

What is the difference between Hashimoto's and Graves'?

Both are autoimmune thyroid diseases. Hashimoto's involves anti-TPO antibodies attacking the thyroid, causing gradual hypothyroidism. Graves' involves TSH-receptor stimulating antibodies, causing hyperthyroidism plus often eye disease and pretibial myxedema.

Can a goiter shrink on its own?

Goiters from acute thyroiditis can shrink as inflammation resolves, often over weeks to months. Iodine-deficiency goiter can shrink with iodine repletion. Hashimoto's-related goiter typically does not regress without levothyroxine.

What happens after thyroid surgery?

After total thyroidectomy, patients require lifelong daily levothyroxine to replace thyroid hormone. After hemithyroidectomy, 60-80% can maintain normal thyroid function without medication. Calcium levels are checked daily for the first 48 hours to detect transient hypocalcemia.

How often should I get thyroid ultrasound for nodules?

Per ATA 2015 guidelines, low-risk nodules (TI-RADS 3) are followed every 12-24 months; intermediate-risk (TI-RADS 4) every 6-12 months until stability is documented; high-risk nodules undergo FNA. Once a nodule is biopsy-proven benign, follow-up ultrasound every 12-24 months is reasonable.

Is radioactive iodine treatment safe?

Radioactive iodine has been used safely for over 75 years to treat Graves' disease and toxic nodular goiter. The main long-term effect is permanent hypothyroidism, treated with levothyroxine. Pregnancy and breastfeeding are absolute contraindications.

Can children get goiter?

Yes. In iodine-deficient regions, school-age goiter prevalence above 5% defines an endemic area. In iodine-sufficient regions, juvenile Hashimoto's is the most common cause, often presenting in adolescent girls with subtle hypothyroidism.

What does a thyroid biopsy feel like?

Fine-needle aspiration is performed in clinic under ultrasound guidance after local anesthetic. A thin needle is passed 2-4 times through the nodule, each pass lasting only seconds. Most patients report mild pressure and brief sharp sensation. Mild soreness and bruising for 1-3 days is normal.

How much does goiter treatment cost?

Levothyroxine and antithyroid drugs are inexpensive generics, typically under USD 15 per month. Ultrasound and TSH testing are covered by most insurance and Medicare. Radioiodine therapy costs USD 1,000-3,000 per treatment in the US.

Neonatal goiter.Care & specialists in Oman

What it is

How you might notice it

How it’s diagnosed

Treatment & cost

Causes & risk factors

Living with it

When to seek help

Related conditions

Easily confused with

Often appears alongside

Types and stages

Living with Neonatal goiter

Patient support resources

Frequently asked

Sources & references

Top Neonatologists in Oman.

Connect with top Neonatologists in Oman.